Rosa Caputo
Impact in
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 11
- HER2/EGFR in Cancer Research 5
- Cancer Treatment and Pharmacology 3
- Cancer-related Molecular Pathways 2
-
- Angiogenesis and VEGF in Cancer 2
- DNA and Nucleic Acid Chemistry 1
- Cancer therapeutics and mechanisms 1
- Co-authors
- Giampaolo Tortora (21 shared papers)Fortunato Ciardiello (20 shared papers)Vincenzo Damiano (16 shared papers)Roberto Bianco (13 shared papers)A R Bianco (10 shared papers)Sabino De Placido (11 shared papers)Gabriella Fontanini (6 shared papers)Teresa Troiani (6 shared papers)
- Journals
- Clinical Cancer Research (5 papers)International Journal of Cancer (4 papers)Proceedings of the National Academy of Sciences (2 papers)Journal of the American College of Cardiology (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Rosa Caputo
21 papers receiving 2.3k citations
Rosa Caputo's Hit Papers
Peers
Comparison fields: 5 of 76
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 738
- Cancer Research 331
- Molecular Biology 935
- Genetics 126
Countries citing papers authored by Rosa Caputo
This map shows the geographic impact of Rosa Caputo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Caputo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Caputo more than expected).
Fields of papers citing papers by Rosa Caputo
This network shows the impact of papers produced by Rosa Caputo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Caputo. The network helps show where Rosa Caputo may publish in the future.
Co-authors
The 25 scholars most cited alongside Rosa Caputo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. Hit paper breakdown → | 2001 | 561 |
| 2 | 2004 | 301 | |
| 3 | Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. | 2003 | 299 |
| 4 | Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa). | 2002 | 213 |
| 5 | Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. | 2003 | 135 |
| 6 | 2002 | 82 | |
| 7 | Helicobacter pylori VacA toxin up-regulates vascular endothelial growth factor expression in MKN 28 gastric cells through an epidermal growth factor receptor-, cyclooxygenase-2-dependent mechanism. | 2003 | 76 |
| 8 | 2005 | 75 | |
| 9 | 2006 | 72 | |
| 10 | 1998 | 70 | |
| 11 | 2001 | 66 | |
| 12 | 2000 | 61 | |
| 13 | 2007 | 59 | |
| 14 | 1997 | 56 | |
| 15 | 2000 | 54 | |
| 16 | Combined targeted inhibition of bcl-2, bcl-XL, epidermal growth factor receptor, and protein kinase A type I causes potent antitumor, apoptotic, and antiangiogenic activity. | 2003 | 49 |
| 17 | 2000 | 47 | |
| 18 | 2004 | 40 | |
| 19 | 2005 | 33 | |
| 20 | 2009 | 30 |
About Rosa Caputo
Rosa Caputo is a scholar working on Oncology, Molecular Biology, Pharmacology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 21 papers that have together received 2.4k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (5 papers), Inflammatory mediators and NSAID effects (3 papers), Cancer Treatment and Pharmacology (3 papers), Angiogenesis and VEGF in Cancer (2 papers), Cancer-related Molecular Pathways (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), DNA and Nucleic Acid Chemistry (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Oncology (1.1k citations), Pulmonary and Respiratory Medicine (738 citations), Cancer Research (331 citations), Molecular Biology (935 citations) and Genetics (126 citations). Rosa Caputo has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Giampaolo Tortora, Fortunato Ciardiello, Vincenzo Damiano, Roberto Bianco, A R Bianco, Sabino De Placido, Gabriella Fontanini, Teresa Troiani, Roberta Caputo and Bianca Maria Veneziani. Their work appears in journals such as Clinical Cancer Research, International Journal of Cancer, Proceedings of the National Academy of Sciences, Journal of the American College of Cardiology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.